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Has1 were regulated upon explantation but their expression appeared to
be independent of FGF2.
Conclusions: Murine cartilage injury mirrors that seen in porcine tissue
and reveals distinct cellular responses to explantation and re-cutting.
The re-cutting response is almost exclusively due to FGF2. Explantation
elicits activation of inﬂammatory signalling and leads to the induction
of genes; both FGF2-dependent, and FGF2-independent. The upstream
pathway through which non-FGF dependent signals are initiated upon
explantation is currently unknown.
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IL-1BETA TRANSLOCATES THE PROTEIN DIMETHYLARGININASE 2
(DDAH2) TO THE MITOCHONDRION OF HUMAN NORMAL CHONDROCYTES
B. Cillero-Pastor, J. Mateos, C. Ruiz-Romero, F.J. Blanco
Osteoarticular and Aging Res. Lab. INIBIC-Complejo Hosp. Univ. A Coruña, A
Coruña, Spain
Purpose: Mitochondria is acquiring an important role in the osteoarthtritis
pathology (OA). IL-1beta is one of the main cytokines related to the in-
ﬂammation and the destruction of the cartilage which is known to regulate
mitochondrial functionality and to produce nitric oxide (NO). Previously,
we have described the total proteome of chondrocytes regulated by IL-
1beta identifying some mitochondrial proteins. Nevertheless, the exact role
that IL-1beta has in the regulation of mitochondrial protein expression and
their implication in the OA process, is not well understood. For this reason,
we analyzed the mitochondrial protein expression proﬁle by the action of
IL-1beta, in order to understand the development of different rheumatic
pathologies.
Methods: Human normal chondrocytes were isolated from the cartilage
of knees of autopsies from donors without previous history of joint dis-
ease. The cells were incubated for 48 hours in basal conditions or with
IL-1beta (5 ng/ml) and mitochondrial proteins were puriﬁed. A pool of
these mitochondrial proteins of 4 different donors in each condition, was
resolved by bidimensional electrophoresis (2-DE). Proteins were visualized
with Sypro stain. The qualitative and quantitative analysis were carried
out with PD-QUEST software. After that, proteins were identiﬁed by mass
spectrometry (MS) using the MALDI-TOF/TOF technology. The validation of
the results and the study of interesting proteins were made by real-time
PCR, western blot and microscopy. Total NO quantiﬁcation was evaluated
with Griess reagent assays.
Results: The comparative analysis of mitochondrial proteome of chon-
drocytes stimulated with IL-1beta for 48 hours with respect to the
basal situation revealed a differential expression of signal transduction
proteins, regulators of cytoskeleton, transcription, metabolic and stress
related pathways. IL-1beta increased with respect to the basal situation
different proteins like annexin A2 (ANXA2) or mitochondrial superoxide
dismutase (SOD2). Another protein that increased its expression 2.59 times
by IL-1beta with respect to basal condition was dimethylargininase 2
(DDAH2) (basal=1, n=4; *P<0.05). This protein has an important role as
regulator of NO synthesis when it hydrolyzes the inhibitor of NO synthase,
ADMA. DDAH2 did not show any regulation at mRNA nor total protein
expression after the stimulation with IL-1beta, nevertheless the study of
mitochondrial extracts showed a clear increase of DDAH2 in the condition
of IL-1beta with respect to the basal situation (4.18±1.41 vs. basal=1, n=4;
*P<0.05). By means of techniques of conventional inmunoﬂuorescence and
confocal microscopy, we observed that DDAH2 was located again in the
mitochondria of IL-1beta-stimulated chondrocytes. These results were also
reproducible in cartilage slices treated with IL-1beta. In addition to this
we demonstrated that DDAH2, which didn’t have been before described
in chondrocytes nor cartilage, regulated the NO production induced by
IL-1beta.
Conclusions: Our studies indicate that IL-1beta increased the expression of
certain proteins with a mitochondrial localization such as DDAH2 that was
identiﬁed for the ﬁrst time in human normal chondrocytes and cartilage.
It seemed to have an important role in the IL-1beta-NO production. Its
speciﬁc localization in the mitochondria could help to understand the role
of this organell and NO in rheumatic pathologies.
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PROTEASE ACTIVATED RECEPTOR-2 (PAR-2) AND ACTIVATED PROTEIN C
(APC) IN CARTILAGE DEGRADATION
M.T. Jackson, M.M. Smith, S. Smith, C. Jackson, C.B. Little
Kolling Inst. of Med. Res., St Leonards, Australia
Introduction: PAR-2 has been implicated in cartilage breakdown in arthritis
because: (i) it is expressed by chondrocytes and upregulated in osteoarthri-
tis (OA) and by IL-1 and TNF; (ii) its activation increases MMP expression
and activity in cartilage in vitro; and (iii) PAR-2 KO mice have reduced
inﬂammatory arthritis. PAR-2 is unique in being activated by APC but not
thrombin. APC is synthesized by chondrocytes and can activate cartilage
MMPs causing cartilage breakdown. In this study we investigated the
role and relationship of PAR-2 and APC in MMP activation and cartilage
degradation.
Methods: Femoral head cartilage from wild-type (WT; C57/BL6) and PAR-2
knock-out (KO) mice was cultured ± 10ng/mL IL-1±20μg/mL APC for 4
days in serum-free media. Glycosaminoglycan (GAG) and collagen (hydrox-
yproline) release, and MMP-2, -9 and -13 activity in conditioned media
were analysed. Chondrocyte expression of matrix proteins and enzymes
was measured by qRT-PCR.
The onset and progression of medial-meniscal-destabilization (DMM)-
induced OA in knees of WT and PAR-2 KO mice was quantiﬁed histo-
logically 4 and 8 weeks after surgery for: cartilage aggrecan loss (0-3),
erosion (0-7), and chondrocyte hypertrophy (0-1); osteophyte size (0-3)
and maturity (0-3); and subchondral bone sclerosis (0-3). All differences
reported below were statistically signiﬁcant p < 0.05.
Results: As previously described in other species, APC alone did not induce
GAG or collagen release from WT mouse cartilage. IL-1-induced GAG re-
lease was augmented by APC, and collagen release was induced in IL-1+APC
cultures. IL-1 increased pro-MMP-9 and active MMP-13 release from WT
mouse cartilage, while IL-1+APC increased active MMP-2, -9 and -13. IL-1
increased mRNA expression for endothelial protein C receptor, ADAMTS-4,
TIMP-1, MMP-9, and this was unaltered by APC. There was no difference in
GAG release, MMP activation or the response to IL-1 ± APC in PAR-2 KO
compared with WT cartilage. PAR-2 KO chondrocytes expressed increased
IL-1-induced ADAMTS-5 mRNA and lacked PAR-2 mRNA compared with
WT. There was a decrease in tibial cartilage aggrecan loss and structural
damage 4 but not 8 weeks after DMM in PAR-2KO mice. There was no
difference in osteophytes between genotypes, but PAR-2 KO mice had
reduced subchondral bone sclerosis at 4 and 8 weeks after DMM.
Discussion: APC activates mouse cartilage MMPs similar to our previous
studies in sheep, with subtle differences associated with articular versus
epiphyseal cartilage. Actual release of collagen from cartilage only occurs
with co-activation of MMP-2, -9 and -13. APC-induced activation of MMPs
and cartilage degradation does not require PAR-2. Furthermore, PAR-2 does
not appear to be critical for IL-1-induced cartilage degradation. The increase
in IL-1-induced ADAMTS-5 mRNA in PAR-2 KO chondrocytes suggests that
activation of PAR-2 normally acts as a negative regulator of this enzyme.
The early inhibition of DMM-induced cartilage damage in PAR-2 KO mice
could be associated with a reduction in the post-surgical inﬂammation.
The early and sustained inhibition in subchondral bone change in PAR-2
KO mice is consistent with the role of PAR-2 in osteoblast activity and
osteoclast differentiation/activation but suggests that cartilage and bone
change in this OA model are not co-dependent.
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IMPAIRED EXPRESSION OF GENES INVOLVED IN REVERSE CHOLESTEROL
TRANSPORT IN HUMAN OSTEOARTHRITIC CHONDROCYTES: BENEFICIAL
EFFECT OF LXR AGONIST TREATMENT
T. Simopoulou, K.N. Malizos, F. Kostopoulou, A. Tsezou
Univ. of Thessalia, Larissa, Greece
Purpose: Osteoarthritis (OA) is a common age-related joint disease. As in
other age-related degenerative diseases, such as those of the cardiovascular
system, altered lipid metabolism has been implicated as a critical player in
disease development. Increased serum cholesterol has been considered a
risk factor for OA independent of obesity and also articular manifestations
have been demonstrated in familial hypercholesterolemia patients.
As excessive accumulation of free cholesterol is toxic for the cells, intra-
cellular cholesterol accumulation is prevented by tight regulation of inﬂux
and eﬄux pathways. We have previously shown that chondrocytes are
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capable of internalizing lipoproteins, via LOX-1 (lectin-like oxidized low
density lipoprotein receptor 1). Once cholesterol is accumulated in cells, its
eﬄux is mediated through reverse cholesterol transport via nuclear factors
LXRa and LXRβ (liver X receptors) and the ATP-binding-cassette transporter
A1 (ABCA1) gene. ABCA1 serves as a lipid pump that eﬄuxes cholesterol
from cells to apolipoprotein A1 (ApoA1). As the accumulation of lipids
in chondrocytes may signify a causal relationship to development and/or
progression of OA, we investigated the expression of genes regulating
reverse cholesterol transport, as ABCA1, ApoA1, LXRa and LXRβ in human
chondrocytes. We also investigated the effect of a synthetic LXR agonist on
apoptosis, ABCA1 and ApoA1 mRNA expression, lipid accumulation, as well
as on COL2A1, AGC, MMP-3, MMP-13 and IL-6 expression levels.
Methods: Articular cartilage samples were obtained from 27 patients with
primary OA undergoing knee replacement surgery, while normal cartilage
was obtained from 8 individuals undergoing fracture repair surgery, with no
history of joint disease. Total cellular RNA was extracted from all samples
and ABCA1, ApoA1, LXRα and LXRβ mRNA and protein expression levels
were evaluated using real-time PCR and Western blot analysis respectively.
The effect of the synthetic LXR agonist TO-901317 was studied after
treatment of osteoarthritic chondrocytes and subsequent investigation of
ABCA1, ApoA1, MMP-13, MMP-3 as well as COL2A1 and AGC mRNA expres-
sion levels. IL-6 was measured with ELISA. Cholesterol eﬄux was evaluated
in osteoarthritic chondrocytes radiolabeled with [1,2(n)-3H] cholesterol
after LXR treatment, while intracellular lipid accumulation was studied
after Oil-red-O staining. Apoptosis was evaluated using ﬂow cytometry.
Results: We found that ApoA1 and ABCA1 mRNA and protein expression
levels were signiﬁcantly lower in osteoarthritic compared to normal carti-
lage (p<0.01 and p<0.001 respectively). In addition, LXRα and LXRβ mRNA
expression levels were also found to be signiﬁcantly lower in osteoarthritic
cartilage (p<0.05 and p<0.01 respectively). Treatment of osteoarthritic
chondrocytes with the LXR agonist TO-901317 resulted in: (i) signiﬁcantly
increased ApoA1 and ABCA1 mRNA expression levels (p<0.01), (ii) signiﬁ-
cant increase in cholesterol eﬄux (p<0.05) (iii) elimination of intracellular
lipids deposits, which had been observed before agonist treatment (iv)
signiﬁcant reduction of MMP-3 and MMP-13 protein levels (p<0.001 and
p<0.01, respectively), (v) signiﬁcant increase by 2 and 6.6-fold in COL2A1
and AGC mRNA expression levels (p<0.05), (vi) signiﬁcant decrease in IL-6
levels (p<0.01) and (vii) signiﬁcant reduction of apoptosis (p<0.005).
Conclusions: Our ﬁndings suggest that impaired expression of genes reg-
ulating cholesterol eﬄux may be a critical player in osteoarthritis, while
the ability of the LXR agonist to facilitate cholesterol eﬄux, results in
reduction of catabolic and inﬂammatory molecules and increase in anabolic
genes’ expression, suggesting its potential use for therapeutic intervention
in osteoarthritis.
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CARTILAGE-SPECIFIC DELETION OF PEROXISOME
PROLIFERATOR-ACTIVATED RECEPTOR GAMMA IN MICE IS ASSOCIATED
WITH GROWTH PLATE DEFECTS
R. Monemdjou1 , G. Perez1, S. Lui2, Q. Yan2, J.-P. Pelletier1,
J. Martel-Pelletier1, F. Beier2, M. Kapoor1
1Univ. of Montreal, Montreal, QC, Canada; 2Univ. of Western Ontario, London,
ON, Canada
Purpose: The majority of long bones develop through a process called
endochondral ossiﬁcation, which involves strict coordination of chondro-
cyte proliferation, differentiation and apoptosis within the growth plate,
thus resulting in the replacement of cartilage by bone. Interplay of the
multitude of intracellular and extracellular factors acting from within and
on chondrocytes results in very tight regulation of these processes, and dis-
turbances of the ﬁne balance controlling endochondral bone growth results
in growth and development-related abnormalities such as dwarﬁsm and
skeletal deformities. The exact mechanisms through which chondrocyte
function/behaviour is controlled during cartilage growth and development
are largely unknown. Peroxisome proliferator-activated receptor gamma
(PPARγ), a transcription factor, plays a key role in lipid homeostasis and
recent studies suggest that PPARγ is involved in the maintenance of bone
homeostasis by contributing to osteoclastogenic and osteoblastogenic path-
ways. However, the speciﬁc in vivo function of PPARγ in chondrogenesis,
and cartilage growth and development is largely unknown. Therefore,
for the ﬁrst time, my study will examine the speciﬁc in vivo contri-
bution of PPARγ to cartilage growth and development processes using
cartilage-speciﬁc PPARγ knockout (KO) mice.
Methods: Cartilage-speciﬁc PPARγ-deﬁcient mice were generated using the
Lox P/Cre system. Using mice at post-natal day zero (P0) and embryonic
16.5 days old (E16.5), the following techniques were used: (1) Histological
staining of long bones with Safranin-O/Fast Green stain to determine the
role of PPARγ in ossiﬁcation patterns, chondrocyte cell shape, and organi-
zation of growth plates. (2) Staining of whole skeletons of newborn mice
with alcian blue/alizarin red to determine skeletal phenotypic changes. (3)
Real-Time PCR and western blotting to determine the expression of extra-
cellular matrix (ECM) markers. (4) Immunohistochemistry for Collagen X
(to determine formation of osseous center), p57 (a marker of hypertrophic
differentiation), and PECAM (cell surface marker for endothelial cells to
account for vascularization).
Results: Newborn wild-type (WT) mice showed that PPARγ is expressed in
all zones of the growth plate of tibias. Although cartilage-speciﬁc PPARγ
KO mice were viable and healthy at least three weeks post-birth, they
showed reduced length, weight, skeletal growth and length of long bones at
birth compared to WT mice. Newborn heterozygous (het) and homozygous
(hom) cartilage-speciﬁc PPARγ KO mice showed growth plate abnormalities
including abnormal growth plate organization and cell shape, reduced cel-
lularity, loss of columnar organization, and shorter hypertrophic zones in a
gene-dose dependent manner. Additionally, immunohistochemistry for p57
showed reduced chondrocyte differentiation in het and hommice compared
to WT mice. Immunohistochemistry for PECAM and Collagen X in long
bones of E16.5 mice revealed reduced vascularity and delayed formation
of osseous center in PPARγ KO mice compared to WT mice. Furthermore,
in vitro studies using PPARγ-deﬁcient chondrocytes showed increased ex-
pression of ECM degradation products including matrix metalloproteinase
(MMP)-13 and ADAMTS-5 (aggrecanase), and decreased expression of ECM
building products including aggrecan and type-II collagen.
Conclusions: This is the ﬁrst report to demonstrate that PPARγ-deﬁciency
in cartilage results in growth plate abnormalities. Overall, we show that
PPARγ plays a potential role in cartilage growth and development in vivo
and its deﬁciency will result in serious musculoskeletal deformities in vivo.
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TRANSGLUTAMINASE 2 INDUCED BY RETINOIC ACID DECREASE HUMAN
CHONDROCYTE APOPTOSIS INDUCED BY HYDROGEN PEROXIDE
M. Lee1, H. Park1, S. Lee1, I. Han1, J. Jang1, I. Kim2, S. Seong1
1Seoul Natl. Univ. Hosp., Seoul, Korea, Republic of; 2Dept. of Biochemistry and
Molecular Biology, Seoul Natl. Univ. Coll. of Med., Seoul, Korea, Republic of
Purpose: Osteoarthritis is a disease characterized by destruction and failure
of the extracellular matrix, which serves as the functional component of
the articular cartilage. The production of extracellular matrix is solely
dependent on the chondrocytes, which makes up the only cell type in the
articular cartilage. Therefore, chondrocyte death and survival are essential
for maintaining the articular cartilage. Transglutaminase 2 (TGase 2) is
an enzyme catalyzing Ca2+-dependent protein cross-linking. TGase 2 has
been shown to be induced and activated during apoptosis. We have previ-
ously shown that TGase 2 expression is increased in human chondrocytes
undergoing apoptosis. Furthermore, inhibition of TGase 2 by monodansyl-
cadaverine (MDC); a competitive substrate of TGase 2; and TGase 2 siRNA
have increased chondrocyte apoptosis. These ﬁndings suggested a possible
protective role of TGase 2 in chondrocyte apoptosis. Retinoic acid (RA) and
its various synthetic analogs affect mammalian cell growth, differentiation,
and apoptosis. RA consistently induces TGase 2 expression and activation,
and it was recently shown that increased TGase 2 expression protected
NIH3T3 cells from apoptosis. The purpose of this study was to demonstrate
whether TGase 2 is induced in human chondrocytes with RA and explore
the role of TGase 2 in human chondrocyte apoptosis.
Methods: 1. Human chondrocytes culture and apoptosis assay. Human
chondrocyte culture, apoptosis induction and analysis of TGase 2 expres-
sion was performed as previously described. Brieﬂy, human chondrocytes
were obtained from the articular cartilage of patients undergoing total
knee arthroplasty and cultured in monolayer. Chondrocyte apoptosis was
induced by treating with H2O2 (1mM) for 24 hours. Apoptosis was as-
sessed by two methods, biochemically by Annexin-V FACS analysis, and
morphologically by nuclear staining for 4’6-Diamidine-2’-phenylliondole
(DAPI).
2. RA treatment. Human chondrocytes were grown in medium containing
10% bovine serum and 1% streptopenicillin at 37°C in a humidiﬁed incuba-
tor with 5% CO2. The cells were starved in medium containing 1% serum
for 48 hours prior to the treatment with 5 μM RA.
